Compare ICUI & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICUI | AXTI |
|---|---|---|
| Founded | 1984 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.6B |
| IPO Year | 1995 | 1998 |
| Metric | ICUI | AXTI |
|---|---|---|
| Price | $176.40 | $63.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $169.00 | $50.50 |
| AVG Volume (30 Days) | 294.2K | ★ 11.6M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.62 | N/A |
| EPS | ★ 1.96 | 0.16 |
| Revenue | ★ $2,231,262,000.00 | $99,361,000.00 |
| Revenue This Year | N/A | $44.70 |
| Revenue Next Year | $4.46 | $42.23 |
| P/E Ratio | ★ $89.34 | $422.44 |
| Revenue Growth | N/A | ★ 31.09 |
| 52 Week Low | $112.50 | $2.83 |
| 52 Week High | $192.85 | $143.16 |
| Indicator | ICUI | AXTI |
|---|---|---|
| Relative Strength Index (RSI) | 51.42 | 46.81 |
| Support Level | $164.09 | $65.02 |
| Resistance Level | $191.07 | $71.49 |
| Average True Range (ATR) | 3.55 | 7.24 |
| MACD | -1.80 | -1.61 |
| Stochastic Oscillator | 3.95 | 9.57 |
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.